lysergic acid diethylamide has been researched along with Fasting Hypoglycemia in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SPENCER, AM | 1 |
1 other study available for lysergic acid diethylamide and Fasting Hypoglycemia
| Article | Year |
|---|---|
MODIFICATIONS IN THE TECHNIQUE OF LSD THERAPY.
Topics: Anxiety; Anxiety Disorders; Brain Chemistry; Drug Therapy; Drug Tolerance; Hospital Design and Const | 1964 |